Sharps Technology, Inc. (NASDAQ:STSS) Sees Large Growth in Short Interest

Sharps Technology, Inc. (NASDAQ:STSS) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 352,700 shares, a growth of 52.9% from the March 31st total of 230,600 shares. Based on an average trading volume of 180,500 shares, the short-interest ratio is currently 2.0 days. Approximately 2.5% of the company’s stock are short sold.

Sharps Technology Trading Down 9.8 %

NASDAQ STSS traded down $0.03 during trading hours on Monday, reaching $0.26. 128,702 shares of the company traded hands, compared to its average volume of 186,091. The company has a 50 day moving average of $0.33 and a two-hundred day moving average of $0.38. Sharps Technology has a 12 month low of $0.26 and a 12 month high of $1.58.

Sharps Technology (NASDAQ:STSS) last posted its quarterly earnings results on Friday, March 29th. The company reported ($0.16) EPS for the quarter.

Institutional Investors Weigh In On Sharps Technology

A hedge fund recently bought a new stake in Sharps Technology stock. Compass Ion Advisors LLC bought a new position in shares of Sharps Technology, Inc. (NASDAQ:STSS) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 57,143 shares of the company’s stock, valued at approximately $32,000. Compass Ion Advisors LLC owned 0.49% of Sharps Technology as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 17.17% of the company’s stock.

Sharps Technology Company Profile

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.